Last reviewed · How we verify
ASCA101
At a glance
| Generic name | ASCA101 |
|---|---|
| Sponsor | MetaFines |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101 (PHASE2)
- Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ASCA101 CI brief — competitive landscape report
- ASCA101 updates RSS · CI watch RSS
- MetaFines portfolio CI